Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Genetic Technologies ( (AU:GTG) ) just unveiled an announcement.
Genetic Technologies Limited has announced the application for quotation of over 1.16 billion fully paid ordinary securities on the Australian Securities Exchange. This move is part of previously announced transactions and could potentially enhance the company’s liquidity and market presence, impacting its operational capabilities and stakeholder interests.
More about Genetic Technologies
Genetic Technologies Limited operates in the biotechnology industry, focusing on genetic testing and diagnostics. The company is known for its development and commercialization of genetic risk assessment tests, primarily targeting the healthcare sector.
Technical Sentiment Signal: Sell
Current Market Cap: A$9.45M
See more insights into GTG stock on TipRanks’ Stock Analysis page.